TY - JOUR
T1 - Deep brain stimulation
T2 - current challenges and future directions
AU - Lozano, Andres M.
AU - Lipsman, Nir
AU - Bergman, Hagai
AU - Brown, Peter
AU - Chabardes, Stephan
AU - Chang, Jin Woo
AU - Matthews, Keith
AU - McIntyre, Cameron C.
AU - Schlaepfer, Thomas E.
AU - Schulder, Michael
AU - Temel, Yasin
AU - Volkmann, Jens
AU - Krauss, Joachim K.
N1 - Publisher Copyright:
© 2019, Springer Nature Limited.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - The clinical use of deep brain stimulation (DBS) is among the most important advances in the clinical neurosciences in the past two decades. As a surgical tool, DBS can directly measure pathological brain activity and can deliver adjustable stimulation for therapeutic effect in neurological and psychiatric disorders correlated with dysfunctional circuitry. The development of DBS has opened new opportunities to access and interrogate malfunctioning brain circuits and to test the therapeutic potential of regulating the output of these circuits in a broad range of disorders. Despite the success and rapid adoption of DBS, crucial questions remain, including which brain areas should be targeted and in which patients. This Review considers how DBS has facilitated advances in our understanding of how circuit malfunction can lead to brain disorders and outlines the key unmet challenges and future directions in the DBS field. Determining the next steps in DBS science will help to define the future role of this technology in the development of novel therapeutics for the most challenging disorders affecting the human brain.
AB - The clinical use of deep brain stimulation (DBS) is among the most important advances in the clinical neurosciences in the past two decades. As a surgical tool, DBS can directly measure pathological brain activity and can deliver adjustable stimulation for therapeutic effect in neurological and psychiatric disorders correlated with dysfunctional circuitry. The development of DBS has opened new opportunities to access and interrogate malfunctioning brain circuits and to test the therapeutic potential of regulating the output of these circuits in a broad range of disorders. Despite the success and rapid adoption of DBS, crucial questions remain, including which brain areas should be targeted and in which patients. This Review considers how DBS has facilitated advances in our understanding of how circuit malfunction can lead to brain disorders and outlines the key unmet challenges and future directions in the DBS field. Determining the next steps in DBS science will help to define the future role of this technology in the development of novel therapeutics for the most challenging disorders affecting the human brain.
UR - http://www.scopus.com/inward/record.url?scp=85060600127&partnerID=8YFLogxK
U2 - 10.1038/s41582-018-0128-2
DO - 10.1038/s41582-018-0128-2
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 30683913
AN - SCOPUS:85060600127
SN - 1759-4758
VL - 15
SP - 148
EP - 160
JO - Nature Reviews Neurology
JF - Nature Reviews Neurology
IS - 3
ER -